Imunon Inc (IMNN) Operating Profitability

Symbol and logo of brand Celsion Corporation (IMNN)

The Imunon, Inc. (IMNN) business model relies on the full outsourcing of DNA synthesis and clinical trials. The operating margin time series demonstrates current cost efficiency, where the value 0.00 captures this metric. Imunon, Inc. (IMNN) is scaling trials for ovarian cancer therapies by securing government grants. An innovative targeted gene delivery method enables the body to fight tumors without the use of toxic chemotherapy.

Imunon Inc (IMNN): Return on Sales by Operating Profit from 04/28/2023 to 11/19/2026

Analytical breakdowns for Imunon Inc (IMNN)

- price and consensus price forecast:
- market capitalization details:
Basic company analysis:Celsion Corporation, IMNN
Core merchandise of Imunon

Operating margin measures the efficiency of the core business, reflecting the share of earnings before interest and taxes relative to revenue to assess net operating leverage. By analyzing the operating margin snapshot, an investor can evaluate the resilience of Imunon, Inc. (IMNN), where high costs associated with recruiting biologists and funding clinical vaccination phases determine the long-term profitability and financial viability of the biotech model.

Competitor analysis

Operating Sales Margin TEM|QGEN - Operating Profitability Margin|Operating Margin IONS|RGEN - Operating Return on Sales|Operating Profitability Avidity RNA|Operating Margin CRISPR Therapeutics Corp CRSP|GeneDx Corp - Operating Margin|Ultragenyx Pharma (RARE) - Operating Sales Margin|beamtx.com (BEAM) - Operating Profitability|SRPT: Operating Profit Ratio|Operating Sales Margin TWST|TXG - Operating Profitability Margin|Operating Margin NTLA|Profitability of Operations Stoke Therapeutics|Operating Profitability BioLife Solutions BLFS|Wave Life Sciences (WVE) - Operating Return on Sales|Maze Therapeutics, Inc. - Operating Margin|Profitability of Operations Sionna Therapeutics, Inc. SION|Prime Medicine Bio (PRME) - Operating Profitability|TSHA: Operating Profit Ratio|Operating Profitability uniQure Pharma|MGTX - Operating Profitability Margin|Operating Margin RGNX|Operating Profitability SLDB (Solid Biosciences)|Ocugen Corp - Operating Sales Margin|PACB: Return on Sales by Operating Profit|benitec.com - Operating Margin|DSGN - Operating Margin|RCKT: Operating Margin|FDMT (4D Molecular Therapeutics Inc) - Operating Profitability|Operating Sales Margin LXEO|Operating Profitability KRRO|Operating Margin EDIT|SLN - Operating Return on Sales|Operating Margin PRQR (ProQR)|CDXS - Operating Sales Margin|Sangamo Therapeutics Inc. - Operating Margin|NAUT - Operating Margin|MGX: Operating Margin|Operating Sales Margin Precision BioSciences, Inc.|GBIO (Generation Bio) - Operating Margin|Boundless Bio Inc. (BOLD) - Profitability of Operations|Operating Sales Margin XCUR (exicuretx.com)|PHIO (Phio Pharmaceuticals Corp.) - Operating Profit Rate|Mustang Bio, Inc. - Operating Sales Margin|RNAZ - Operating Sales Margin|BNGO: Operating Sales Margin|APDN (Applied DNA Sciences Inc) - Return on Sales by Operating Profit|BLUE (Bluebird Bio) - Operating Sales Margin|ImmunoPrecise Antibodies Ltd - Operating Profit Rate|OMGA (Omega Therapeutics Inc) - Operating Margin|Operating Profitability OMIC|Operating Profitability Regulus Therapeutics Inc. (RGLS)|Operating Sales Margin Syros Pharmaceuticals, Inc. SYRS|Telesis Bio - Operating Sales Margin|Operating Profit Rate TCON|UBX - Operating Profitability